What Is a Cardiac Stress Test? What It Shows and What It Misses.

A cardiac stress test is designed to answer one specific question: does physical exertion produce evidence of myocardial ischemia? It answers that question by increasing cardiac demand through exercise or pharmacological stress and monitoring the heart’s response through electrocardiographic changes, imaging, or both. Understanding what question the test is and is not answering is what makes a result clinically interpretable, and what prevents a man from walking away from a normal test with a false sense of complete reassurance.

The Mechanism

The stress test exploits a physiological principle: coronary stenoses that are not severe enough to restrict blood flow at rest will produce ischemia during exertion, when myocardial oxygen demand rises substantially. At peak exercise, cardiac output may increase four to six times over resting values. A stenosis of 70 to 80 percent of the luminal diameter may allow adequate resting perfusion while creating a critical flow limitation during exercise. Downstream myocardium becomes ischemic. That ischemia produces detectable changes: ST-segment depression on ECG, regional wall motion abnormalities on echocardiography, or perfusion defects on nuclear imaging.

The key phrase is “hemodynamically significant stenosis.” The stress test is a functional test. It detects physiological consequences, specifically the failure of blood supply to meet demand. It does not image the coronary arteries directly. It does not detect whether plaque is present. It does not distinguish between a 40 percent stenosis with a vulnerable, rupture-prone fibrous cap and a stable 40 percent stenosis with a thick, calcified cap. Both would pass a standard stress test. One of them may cause a fatal MI within the year.

This is not a criticism of the stress test. It is a description of what it does. The stress test is built to detect flow-limiting disease. That is a clinically important question in the right setting. The problem arises when it is used to answer a different question: is this man free of coronary artery disease? It was never designed to answer that.

The physiology of demand ischemia also explains why symptoms are part of the test. A man who develops chest pressure, jaw tightness, or left arm heaviness during exercise, even in the absence of ECG changes, has reported clinically significant information. Symptoms during a stress test carry independent prognostic weight beyond the electrocardiographic findings. A man who exercises to 90 percent of his predicted maximum heart rate without symptoms and without ECG changes has demonstrated adequate functional coronary reserve for that workload. A man who develops symptoms at 65 percent of his predicted maximum has reported an important threshold, regardless of whether the ECG is abnormal.

The Types of Stress Test

Standard treadmill ECG stress test (exercise stress test): The patient walks and then runs on a treadmill through a standardized protocol while the ECG is monitored continuously. The Bruce protocol is most common: stages of increasing speed and grade every three minutes. ST-segment changes, specifically horizontal or downsloping ST depression of at least 1 mm in two or more leads, are the primary electrocardiographic criterion for a positive test suggesting ischemia.

Heart rate response, blood pressure response, exercise duration, metabolic equivalent achieved, and symptoms are all recorded and contribute to overall test interpretation. Failure to reach 85 percent of age-predicted maximum heart rate limits the diagnostic utility of the test: a “negative” test in a man who could only exercise to 60 percent of his maximum because of deconditioning may not reflect adequate coronary stress.

Diagnostic accuracy: sensitivity approximately 68 percent and specificity approximately 77 percent for obstructive coronary artery disease in men with intermediate pre-test probability. 4 / Promising These numbers mean the test misses roughly 30 percent of significant stenoses in this population and incorrectly flags roughly 23 percent of men without significant disease. Pre-test probability matters: in low-risk men, false positive rates are high; in high-risk men, the test’s positive predictive value improves substantially.

Stress echocardiogram: Ultrasound imaging of the heart at rest and at peak stress. Regional wall motion abnormalities that appear during stress reflect ischemia in the corresponding coronary territory. Sensitivity is approximately 80 to 85 percent and specificity approximately 85 to 90 percent for obstructive coronary disease, superior to standard ECG stress testing in most comparative studies. The tradeoff is operator-dependence: image quality and interpretation depend on sonographer and cardiologist experience. 4 / Promising

Nuclear stress test (myocardial perfusion imaging): A radiotracer (most commonly technetium-99m sestamibi) is injected at rest and at stress. Gamma camera imaging produces comparative maps of myocardial blood flow. Perfusion defects that appear only with stress indicate ischemia in viable myocardium. Defects present at both rest and stress typically indicate prior infarction with scar. Sensitivity approximately 85 to 90 percent, specificity approximately 75 to 85 percent for significant coronary artery disease. 4 / Promising The lower specificity reflects artifacts from breast attenuation in women (less relevant in men) and diaphragm attenuation in men with larger body habitus.

Pharmacological stress: For men who cannot exercise adequately (orthopedic limitations, severe deconditioning, peripheral vascular disease), pharmacological agents produce the physiological stress instead of exercise. Regadenoson and adenosine are vasodilatory agents that maximize coronary blood flow; in the presence of a significant stenosis, the downstream territory does not dilate proportionally and appears as a relative perfusion defect. Dobutamine is an inotropic agent used for pharmacological stress echocardiography. These tests evaluate the same endpoint as exercise-based testing but provide no information about exercise capacity or symptom-limited functional threshold.

What the Stress Test Does Not Catch

The most consequential limitation of the stress test in the context of primary prevention is that it does not detect non-obstructive plaque. Atherosclerosis begins in the arterial wall, beneath the intimal surface. Early and intermediate plaques may produce 30 to 50 percent luminal stenosis. These are not hemodynamically significant at rest or at peak exercise. They do not impair coronary blood flow during the test. The stress test is normal.

The danger is that non-obstructive plaque is not stable plaque. A lipid-rich, poorly calcified plaque with a thin fibrous cap is prone to rupture regardless of its stenosis severity. When the fibrous cap tears, the underlying lipid core is exposed to the bloodstream. Platelet aggregation, thrombus formation, and acute lumen occlusion can follow within minutes. This is the mechanism of the acute MI that strikes men who passed a stress test six months earlier.

The PROSPECT trial (Stone et al., NEJM 2011) followed 697 patients with recent acute coronary syndrome after coronary angiography and intravascular ultrasound of all coronary segments. At three-year follow-up, major adverse events occurred in 11.6 percent of patients. Of the events attributable to non-culprit lesions (lesions not responsible for the presenting ACS), 51 percent arose from lesions that were non-flow-limiting at baseline. The majority of these would have passed any standard functional stress test. (Stone et al., NEJM 2011) 5 / Solid

This is why the stress test and the coronary artery calcium score are not interchangeable tests addressing the same question. The CAC score detects whether atherosclerosis has materialized in the coronary wall by measuring the total calcium burden in coronary plaque. It does not tell you whether the plaque is flow-limiting. It tells you whether it is there. A man with a CAC of 350 who passes a stress test has two accurate, non-contradictory pieces of information: he has significant coronary atherosclerosis, and it is not yet producing hemodynamically significant stenosis. That combination defines a high-risk patient who needs aggressive lipid and blood pressure treatment, not a reassured patient.

When a Stress Test Is the Right Tool

Symptomatic men with known or suspected coronary disease: evaluating whether a known lesion produces ischemia during exercise, guiding exercise safety recommendations, or clarifying whether revascularization is indicated. This is the stress test’s home territory.

Men with exertional symptoms of uncertain cause: when a man describes chest discomfort, jaw tightness, or dyspnea with exertion and the clinical question is whether exercise is producing myocardial ischemia, the stress test is the appropriate initial diagnostic step.

Pre-operative evaluation: before high-risk elective surgery in a man with cardiovascular risk factors who has poor functional capacity or known coronary disease, functional assessment determines whether further workup or optimization is needed before proceeding.

Return to activity after cardiac event: guiding exercise prescription after MI, coronary revascularization, or heart failure hospitalization. The functional threshold established during a post-event stress test directly informs the cardiac rehabilitation exercise prescription.

Surveillance in known coronary disease: men with established coronary artery disease who develop new or changed symptoms warrant functional reassessment to determine whether disease has progressed in a way that produces new ischemia.

When the CAC Score or Coronary CTA Is More Appropriate

Asymptomatic men in primary prevention where the goal is risk stratification: CAC score. This is the most common scenario where a stress test is ordered inappropriately. An asymptomatic man who wants to know whether he has coronary artery disease will get a more direct answer from a CAC score than from a stress test, because the CAC score directly images the atherosclerotic burden in the coronary walls.

Stable chest pain in a man without prior coronary disease where the clinical question is anatomical: coronary CTA. The PROMISE trial (Douglas et al., NEJM 2015) compared coronary CTA to standard functional stress testing in 10,003 patients with stable symptoms. At a median follow-up of 25 months, cardiovascular death or non-fatal MI was similar between groups, but coronary CTA led to more efficient downstream testing: fewer unnecessary catheterizations, more appropriate identification of obstructive disease, and lower rates of invasive procedures in patients who turned out not to have significant disease. (Douglas et al., NEJM 2015) 4 / Promising

Post-positive stress test clarification: before proceeding to invasive coronary angiography in a man with an abnormal functional test, coronary CTA with fractional flow reserve (FFRct) can anatomically characterize which lesions are physiologically significant and which are not.

Interpreting the Result

A positive stress test, defined as ischemic ST changes, new wall motion abnormalities, or significant perfusion defects during stress, indicates probable obstructive coronary artery disease and warrants further evaluation. In most current guidelines, coronary CTA with FFRct is the preferred next step to anatomically characterize which lesions are significant before considering invasive testing.

A negative stress test means no evidence of significant flow-limiting stenosis was detected at the workload achieved. It does not mean the coronary arteries are free of atherosclerosis. If the patient did not reach adequate heart rate (85 percent of age-predicted maximum), the test is non-diagnostic and the interpretation is limited.

An inconclusive or equivocal stress test (borderline ST changes, submaximal heart rate, new symptoms without ECG changes) typically warrants additional testing with a more sensitive imaging modality: stress echocardiogram, nuclear perfusion imaging, or coronary CTA depending on the clinical context and the question being answered.

What to Do This Week

1. If your physician has recommended a stress test, ask what specific clinical question it is meant to answer. If the question is “does this man have coronary artery disease,” ask whether a CAC score or coronary CTA would provide more direct anatomical information about your specific situation.

2. If you have had a negative stress test and continue to have exertional symptoms, or develop new symptoms in the months following, that normal result does not exclude coronary artery disease. A coronary CTA that directly images the vessel walls is the appropriate next step, not reassurance based on a prior functional test.

3. If you are asymptomatic and wondering whether a stress test would tell you about your cardiovascular health: the honest answer is that it depends on what you want to know. For primary prevention risk stratification, a CAC score is the more direct answer. For determining whether you can exercise safely at high intensity, the stress test provides information the CAC score cannot.

4. If you have a known CAC score above 100 and no prior functional testing, discuss with your cardiologist whether a stress test is appropriate to establish whether any of the identified plaque is already producing flow limitation during exertion.

5. If you have been told your stress test was “normal” and are using that to defer other cardiovascular risk assessment, reconsider. Ask whether your ApoB has been measured, whether your blood pressure is at target, and whether your 10-year ASCVD risk has been calculated. The normal stress test is one answer to one question, not a complete cardiovascular assessment.

The stress test remains a valuable clinical tool in the right setting. Understanding what it does and does not detect is what determines whether you are using it to answer the right question.